Adverse reactions to radiopharmaceuticals.
D000792:Angiography / Q000009:adverse effects; D002717:Chlormerodrin / Q000009:adverse effects; D002758:Cholangiography / Q000009:adverse effects; D003102:Colloids; D006048:Gold Colloid, Radioactive / Q000009:adverse effects; D006801:Humans; D007204:Indium / Q000009:adverse effects; D007457:Iodine Radioisotopes; D007465:Iodohippuric Acid / Q000009:adverse effects; D008629:Mercury Isotopes / Q000009:adverse effects; D004369:Pentetic Acid / Q000009:adverse effects; D010759:Phosphorus Isotopes / Q000009:adverse effects; D011868:Radioisotopes / Q000009:adverse effects*; D012709:Serum Albumin / Q000009:adverse effects; D012711:Serum Albumin, Radio-Iodinated / Q000009:adverse effects; D013325:Strontium Isotopes / Q000009:adverse effects; D013667:Technetium / Q000009:adverse effects; D014567:Urography / Q000009:adverse effects
D003102:Colloids; D006048:Gold Colloid, Radioactive; D007457:Iodine Radioisotopes; D008629:Mercury Isotopes; D010759:Phosphorus Isotopes; D011868:Radioisotopes; D012709:Serum Albumin; D012711:Serum Albumin, Radio-Iodinated; D013325:Strontium Isotopes; D007204:Indium; D007465:Iodohippuric Acid; D013667:Technetium; D004369:Pentetic Acid; D002717:Chlormerodrin